GLP-1 News

Millions are losing weight on Ozempic and Wegovy — here's what an orthopedic surgeon wants every patient to know - Yahoo Creators

Millions are losing weight on Ozempic and Wegovy — here's what an orthopedic surgeon wants every patient to know  Yahoo Creators

GLP-1s and Alcohol Use Disorder; No Luck With Gonorrhea Vaccine

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick…

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk - Medical Daily

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk  Medical Daily

Study Links GLP-1s to Lower Risk of Fragility Fractures in Diabetes Patients

(MedPage Today) -- Starting a GLP-1 receptor agonist for type 2 diabetes was associated with a lower risk of fragility fractures in adults 50 and older, including hip and…

GLP-1s Like Ozempic, Wegovy Can Help Maintain Lower Calorie Intake for Over 1 Year - Healthline

GLP-1s Like Ozempic, Wegovy Can Help Maintain Lower Calorie Intake for Over 1 Year  Healthline

The Oral GLP-1 Tracker: Obesity prescriptions jump for both Novo and Lilly - Fierce Pharma

The Oral GLP-1 Tracker: Obesity prescriptions jump for both Novo and Lilly  Fierce Pharma

Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50% - Stocktwits

Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%  Stocktwits

Novo Nordisk Doubles Down On Efforts To Halt Lilly Tirzepatide Ads - insights.citeline.com

Novo Nordisk Doubles Down On Efforts To Halt Lilly Tirzepatide Ads  insights.citeline.com

What Are Compounders Commonly Adding to GLP-1 Drugs?

(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz

Novo seeks injunction to stop Lilly's 'false and misleading' GLP-1 ads - FirstWord Pharma

Novo seeks injunction to stop Lilly's 'false and misleading' GLP-1 ads  FirstWord Pharma

Five Ways to Get the Most from a GLP-1 Medication - AOL.com

Five Ways to Get the Most from a GLP-1 Medication  AOL.com

AI helps Stanford scientists discover “natural Ozempic” without the usual side effects

Stanford Medicine researchers have discovered a naturally occurring molecule that may suppress appetite and reduce body weight much like Ozempic, but without several of its common…

Combining Tirzepatide With Niacinamide: Potential Benefits, Side Effects And Safety Considerations - Forbes

Combining Tirzepatide With Niacinamide: Potential Benefits, Side Effects And Safety Considerations  Forbes

Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma

Novo is seeking an injunction that would halt allegedly “misleading” obesity drug ads. Elsewhere, the FDA began reviewing a highly anticipated medicine and a veteran investor…

The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients - ScienceDaily

The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients  ScienceDaily

Weight loss drugs linked to higher risk alopecia, study finds - Female First

Weight loss drugs linked to higher risk alopecia, study finds  Female First

Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic - The Guardian

Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic  The Guardian

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits - News-Medical

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits  News-Medical

TGA issues new warning after finding link between GLP-1 medicines Ozempic, Wegovy, Mounjaro to eye disorder - The West Australian

TGA issues new warning after finding link between GLP-1 medicines Ozempic, Wegovy, Mounjaro to eye disorder  The West Australian

Ozempic and Mounjaro linked to a surprising hair loss risk - ScienceDaily

Ozempic and Mounjaro linked to a surprising hair loss risk  ScienceDaily

Weight loss drugs linked to increased risk of hair loss, researchers say - Sky News

Weight loss drugs linked to increased risk of hair loss, researchers say  Sky News

Rare eye disorder linked to Ozempic-like medications - ABC News & Headlines – Australian Broadcasting Corporation

Rare eye disorder linked to Ozempic-like medications  ABC News & Headlines – Australian Broadcasting Corporation

The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors - Yahoo Creators

The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors  Yahoo Creators

GLP-1 Jabs Linked to Rare Side Effect That’s Worse Than ‘Ozempic Face’ - The Daily Beast

GLP-1 Jabs Linked to Rare Side Effect That’s Worse Than ‘Ozempic Face’  The Daily Beast

Singing for Chronic Belching; Excess Cancers in Crohn's; Dual Agonist for Liver Fat

(MedPage Today) -- In a Chinese randomized trial, structured singing therapy for supragastric belching led to significantly greater response rates compared with diaphragmatic…

Ozempic may have a scary effect on your hair - Fast Company

Ozempic may have a scary effect on your hair  Fast Company

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Advertising Claims - Law Commentary

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Advertising Claims  Law Commentary

Lilly, with new data, to seek FDA approval of obesity drug retatrutide

The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on…

New studies reveal rare but real risk of GLP-1 drugs - New York Post

New studies reveal rare but real risk of GLP-1 drugs  New York Post

A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing

Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of…

How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q2 Results? - Yahoo Finance UK

How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q2 Results?  Yahoo Finance UK

STAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more

A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk

STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit

On analyses that looked at major cardiovascular events, those taking retatrutide did not have a significant lower risk of death, heart attack, or stroke.

Ozempic And Wegovy May Boost Workplace Productivity: New Study Links GLP-1 Drugs to a 17% Drop in Sick Days - International Business Times

Ozempic And Wegovy May Boost Workplace Productivity: New Study Links GLP-1 Drugs to a 17% Drop in Sick Days  International Business Times

New warning for Ozempic, Wegovy and Mounjaro over serious eye disorder including blindness - 7NEWS

New warning for Ozempic, Wegovy and Mounjaro over serious eye disorder including blindness  7NEWS

Warning to anyone on Mounjaro, Wegovy or Ozempic as drugs linked to hair loss - Wales Online

Warning to anyone on Mounjaro, Wegovy or Ozempic as drugs linked to hair loss  Wales Online

Weight loss drugs such as Mounjaro and Wegovy ‘linked to hair loss’ - Radio News Hub

Weight loss drugs such as Mounjaro and Wegovy ‘linked to hair loss’  Radio News Hub

GLP-1 Medications Linked to Increased Hair Loss in New Study — Here’s How Much They Raise the Risk of Alopecia - People.com

GLP-1 Medications Linked to Increased Hair Loss in New Study — Here’s How Much They Raise the Risk of Alopecia  People.com

Stopping Ozempic, Wegovy May Reverse Cardiovascular Benefits - AOL.com

Stopping Ozempic, Wegovy May Reverse Cardiovascular Benefits  AOL.com

Hair loss with GLP-1 drugs is rare, but real, studies find - The Mighty 790 KFGO

Hair loss with GLP-1 drugs is rare, but real, studies find  The Mighty 790 KFGO

Hair loss with GLP-1 drugs is rare, but real, studies find - Reuters

Hair loss with GLP-1 drugs is rare, but real, studies find  Reuters

New Study Links GLP-1s to Hair Loss

(MedPage Today) -- Adults with type 2 diabetes who used a GLP-1 receptor agonist had an increased risk of clinically recorded hair loss, data from a target trial emulation…

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads - FOX 13 Tampa Bay

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads  FOX 13 Tampa Bay

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads - LiveNOW from FOX

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads  LiveNOW from FOX

GLP-1s for Addiction; DEA's Ketamine Crackdown; ADHD and Social Media

(MedPage Today) -- The use of GLP-1 receptor agonists was associated with a lower risk of alcohol-related hospitalization in adults with alcohol addiction, a retrospective study…

Novo Nordisk sues Eli Lilly over GLP-1 advertising claims - Benefits and Pensions Monitor

Novo Nordisk sues Eli Lilly over GLP-1 advertising claims  Benefits and Pensions Monitor

New study links GLP-1 drugs to fewer knee replacements - Benefits and Pensions Monitor

New study links GLP-1 drugs to fewer knee replacements  Benefits and Pensions Monitor

Novo Nordisk Sues Eli Lilly Over Zepbound Weight Claims - 조선일보

Novo Nordisk Sues Eli Lilly Over Zepbound Weight Claims  조선일보

Ozempic maker Novo Nordisk sues Mounjaro maker Eli Lilly over alleged misleading advertising - bestmediainfo.com

Ozempic maker Novo Nordisk sues Mounjaro maker Eli Lilly over alleged misleading advertising  bestmediainfo.com

Novo Nordisk stock trades near record territory as Ozempic and Wegovy drive growth - Ad-hoc-news.de

Novo Nordisk stock trades near record territory as Ozempic and Wegovy drive growth  Ad-hoc-news.de

Newer obesity drugs linked to fewer alcohol-related hospitalizations for people with alcohol dependence - Medical Xpress

Newer obesity drugs linked to fewer alcohol-related hospitalizations for people with alcohol dependence  Medical Xpress

Novo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It’s Suing - International Business Times

Novo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It’s Suing  International Business Times

GLP-1 Maker Sued Over Ads; Vaginal Estrogen; Melinda Gates Talks Perimenopause

(MedPage Today) -- Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance. (Reuters via NBC News) GLP-1 drug…

GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds - CBS News

GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds  CBS News

Why Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads - Pharmaceutical Commerce

Why Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads  Pharmaceutical Commerce

Novo Nordisk sues Eli Lilly over misleading GLP-1 advertising - Biostock

Novo Nordisk sues Eli Lilly over misleading GLP-1 advertising  Biostock

Novo Nordisk sues Eli Lilly over ‘misleading’ Zepbound and Mounjaro ads - Medical Marketing and Media

Novo Nordisk sues Eli Lilly over ‘misleading’ Zepbound and Mounjaro ads  Medical Marketing and Media

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data - PharmTech.com

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data  PharmTech.com

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…

Ozempic Beats Steroids Against Brain TB Inflammation in Multi-Model Study - Tech Times

Ozempic Beats Steroids Against Brain TB Inflammation in Multi-Model Study  Tech Times

Novo Nordisk sues rival over obesity drug ads - ICLG

Novo Nordisk sues rival over obesity drug ads  ICLG

Ozempic-maker Novo Nordisk accuses rival Eli Lilly of false advertising - BBC

Ozempic-maker Novo Nordisk accuses rival Eli Lilly of false advertising  BBC

Novo Nordisk stock trades near record levels as Ozempic and Wegovy fuel double digit growth - Ad-hoc-news.de

Novo Nordisk stock trades near record levels as Ozempic and Wegovy fuel double digit growth  Ad-hoc-news.de

STAT+: Anthropic deepens work with rare disease drugs

Novo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The Readout

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads - Fierce Pharma

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads  Fierce Pharma

Live Updates: Insurance Coverage for GIP and GLP-1 Agonists Like Zepbound & Wegovy in 2026 - GoodRx

Live Updates: Insurance Coverage for GIP and GLP-1 Agonists Like Zepbound & Wegovy in 2026  GoodRx

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly - GlobeNewswire

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly  GlobeNewswire

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly - Carroll County Mirror-Democrat

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly  Carroll County Mirror-Democrat

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly - WBOC TV

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly  WBOC TV

STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to make its obesity and diabetes drugs appear more effective.

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages - U.S. News & World Report

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages  U.S. News & World Report

Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness - WSB-TV

Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness  WSB-TV

Troubling Findings in Study of GLP-1 Compounders - MedPage Today

Troubling Findings in Study of GLP-1 Compounders  MedPage Today

Troubling Findings in Study of GLP-1 Compounders

(MedPage Today) -- The market for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many…

Novo Nordisk stock trades near record levels as Ozempic and Wegovy drive double digit growth - Ad-hoc-news.de

Novo Nordisk stock trades near record levels as Ozempic and Wegovy drive double digit growth  Ad-hoc-news.de

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages - Drug Topics

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages  Drug Topics

STAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and more

Some former employees say telehealth company LifeMD has sought to maximize the volume of GLP-1 prescriptions at the expense of patient safety

HHS vaccine committee quietly gets new charter

Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more health news

Semaglutide and tirzepatide extend GLP-1 benefits to liver health, mobility & longevity - Nutrition Insight

Semaglutide and tirzepatide extend GLP-1 benefits to liver health, mobility & longevity  Nutrition Insight

Ozempic, Wegovy, Ro: GLP-1 ads are taking over social media - Mashable

Ozempic, Wegovy, Ro: GLP-1 ads are taking over social media  Mashable

The Upside-Down World of the GLP-1 Bridge

(MedPage Today) -- I spent 10 minutes in complete silence in my patient's room today, my eyes scanning lines of text in the electronic medical record. I wasn't looking for a…

Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies - Business Insider Africa

Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies  Business Insider Africa

GLP-1 weight loss drugs like Ozempic, Wegovy and Zepbound keep Long Island plastic surgeons busy - Newsday

GLP-1 weight loss drugs like Ozempic, Wegovy and Zepbound keep Long Island plastic surgeons busy  Newsday

Orforglipron vs. Tirzepatide: What Are the Major Differences? - GoodRx

Orforglipron vs. Tirzepatide: What Are the Major Differences?  GoodRx

GLP-1 Drugs Like Ozempic, Wegovy May Help With Binge Eating Disorder - Healthline

GLP-1 Drugs Like Ozempic, Wegovy May Help With Binge Eating Disorder  Healthline

Zepbound: GLP-1s May Raise Frailty, Muscle Loss Risk in Older Adults - Healthline

Zepbound: GLP-1s May Raise Frailty, Muscle Loss Risk in Older Adults  Healthline

GLP-1 Shortage Deepens in Two States as Demand Remains High - Bioengineer.org

GLP-1 Shortage Deepens in Two States as Demand Remains High  Bioengineer.org

FDA to review Amneal's, Adalvo's 2 ANDAs for generic tirzepatide autoinjector - Drug Store News

FDA to review Amneal's, Adalvo's 2 ANDAs for generic tirzepatide autoinjector  Drug Store News

Compounders maintain a firm grip on the GLP-1 market

Despite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients are still taking cheaper weight-loss alternatives.

The Ozempic Mystery — Why Your Friend Lost 60 Pounds On A GLP-1… And You Didn’t - MadameNoire

The Ozempic Mystery — Why Your Friend Lost 60 Pounds On A GLP-1… And You Didn’t  MadameNoire

Stopping Ozempic or Wegovy Leads to Nearly 2 Pounds of Weight Regain Per Month, Largest Review Finds - Medical Daily

Stopping Ozempic or Wegovy Leads to Nearly 2 Pounds of Weight Regain Per Month, Largest Review Finds  Medical Daily

Does stopping a GLP-1 really doom you to regain all the weight? - NBC News

Does stopping a GLP-1 really doom you to regain all the weight?  NBC News

Doctors Warn Some Ozempic and Wegovy Users With ALS Could Face Faster Disease Progression - wowo.com

Doctors Warn Some Ozempic and Wegovy Users With ALS Could Face Faster Disease Progression  wowo.com

Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits - AboutLawsuits.com

Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits  AboutLawsuits.com

Compounded GLP-1s: Why doctors worry and the FDA is cracking down - Stanford Medicine

Compounded GLP-1s: Why doctors worry and the FDA is cracking down  Stanford Medicine

Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders - Fox News

Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders  Fox News

People Can Lose Their Zest for Life After Starting GLP-1s, Docs Warn - Gizmodo

People Can Lose Their Zest for Life After Starting GLP-1s, Docs Warn  Gizmodo

VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated - ACCESS Newswire

VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated  ACCESS Newswire

VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated - Newswire.com

VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated  Newswire.com

Wegovy and Mounjaro could be used to treat patients with eating disorders - AOL.com

Wegovy and Mounjaro could be used to treat patients with eating disorders  AOL.com

GLP-1 Fraud: Asheville Wellness Owner Charged With Distributing Unlicensed Tirzepatide - Tech Times

GLP-1 Fraud: Asheville Wellness Owner Charged With Distributing Unlicensed Tirzepatide  Tech Times

‘Ozempic Feet:’ What Causes This Unusual GLP-1 Side Effect? - Healthline

‘Ozempic Feet:’ What Causes This Unusual GLP-1 Side Effect?  Healthline

STAT+: Celcuity’s breast cancer drug approved, its first

FDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The Readout

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

(MedPage Today) -- Note that some links may require registration or subscription. A preprint study flagged signals of frailty in seniors taking the GLP-1 drug tirzepatide…

Dulaglutide For Weight Loss: Benefits, Dosage And Side Effects - Forbes

Dulaglutide For Weight Loss: Benefits, Dosage And Side Effects  Forbes

STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expect

A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has taken the world by storm.

GLP-1 weight-loss drugs may lower the need for knee replacement - Harvard Health

GLP-1 weight-loss drugs may lower the need for knee replacement  Harvard Health

GLP-1s Good for Marriage Prospects? RFK Jr.'s Diabetes Ads Axed; CGMs for Toddlers

(MedPage Today) -- GLP-1 drugs did not appear to improve diabetes patients' job or marriage prospects, according to a working paper from the National Bureau of Economic Research.…

GLP-1s and Blinding Condition; Cyclosporiasis Source Found? Tylenol-Autism Lawsuits

(MedPage Today) -- Note that some links may require registration or subscription. A cohort study found that diabetes patients taking GLP-1 receptor agonists had a higher risk of…

GLP-1 Drugs Like Ozempic and Wegovy May Be Improving a Painful Skin Disease, Dermatologists Say - Medical Daily

GLP-1 Drugs Like Ozempic and Wegovy May Be Improving a Painful Skin Disease, Dermatologists Say  Medical Daily

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging - ScienceDaily

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging  ScienceDaily

Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications - Rutgers University

Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications  Rutgers University

Tirzepatide vs semaglutide for weight loss: What’s the difference? - MSN

Tirzepatide vs semaglutide for weight loss: What’s the difference?  MSN

Obesity Drugs Lose Weight, but Not Necessarily Improve Quality of Life - VOI.id

Obesity Drugs Lose Weight, but Not Necessarily Improve Quality of Life  VOI.id

Wegovy More Likely To Cause Rare Blindness Than Ozempic And Other Similar Drugs, Recent Study Finds - Health and Me

Wegovy More Likely To Cause Rare Blindness Than Ozempic And Other Similar Drugs, Recent Study Finds  Health and Me

New Analysis Links Wegovy to a Rare Eye Condition That Can Cause Sudden, Permanent Vision Loss - Medical Daily

New Analysis Links Wegovy to a Rare Eye Condition That Can Cause Sudden, Permanent Vision Loss  Medical Daily

GLP-1s Grow Up: What the Latest Research Means for People Taking Them - The Killeen Daily Herald

GLP-1s Grow Up: What the Latest Research Means for People Taking Them  The Killeen Daily Herald

Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes

(MedPage Today) -- Adding a GLP-1 receptor agonist was not associated with a lower likelihood of discontinuing existing basal insulin therapy among veterans with type 2 diabetes…

Can GLP-1s be more transformative than AI - one person believes they already are - PharmaDispatch

Can GLP-1s be more transformative than AI - one person believes they already are  PharmaDispatch

FDA Accepts Sandoz Generic Tirzepatide Applications Amid Biosimilar Development Gap - Center for Biosimilars

FDA Accepts Sandoz Generic Tirzepatide Applications Amid Biosimilar Development Gap  Center for Biosimilars

Tirzepatide vs. Semaglutide: What You Should Know - Cleveland Clinic Health Essentials

Tirzepatide vs. Semaglutide: What You Should Know  Cleveland Clinic Health Essentials

Tirzepatide Costs, Insurance Coverage & Savings Tips - Forbes

Tirzepatide Costs, Insurance Coverage & Savings Tips  Forbes

‘Ozempic feet:’ the latest side effect among GLP-1 users, doctors warn - KTLA

‘Ozempic feet:’ the latest side effect among GLP-1 users, doctors warn  KTLA

Zevay GLP-1 Review 2026: Could This Lower-Cost Telehealth Option Be the Right Fit for Your Weight-Management Goals? - Newswire.com

Zevay GLP-1 Review 2026: Could This Lower-Cost Telehealth Option Be the Right Fit for Your Weight-Management Goals?  Newswire.com

DOJ sues OhioHealth over alleged anticompetitive hospital contracts; Novo to slash Ozempic, Wegovy prices up to 50% in 2027; lightweight ‘exoskeleton’ helps stroke survivors walk – Morning Medical Update - Medical Economics

DOJ sues OhioHealth over alleged anticompetitive hospital contracts; Novo to slash Ozempic, Wegovy prices up to 50% in 2027; lightweight ‘exoskeleton’ helps stroke survivors walk…

What are ‘Ozempic feet’? Doctors warn of surprising weight-loss side effect - NewsNation

What are ‘Ozempic feet’? Doctors warn of surprising weight-loss side effect  NewsNation

Comparing Ozempic, Wegovy and Other GLP-1 Drugs - GoodRx

Comparing Ozempic, Wegovy and Other GLP-1 Drugs  GoodRx

GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More - GoodRx

GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More  GoodRx

5 Tips for Switching from Injectable to Oral GLP-1s - GoodRx

5 Tips for Switching from Injectable to Oral GLP-1s  GoodRx

Study Compares GLP-1 Drugs on Their Benefits, Harms

(MedPage Today) -- Variable weight-loss and cardiovascular benefits were seen with GLP-1 drugs in a systematic review and network meta-analysis, but effects on quality of life…

If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It - BuzzFeed

If A GLP-1 Medication Has Changed Your Life For The Better, We Want To Hear About It  BuzzFeed

GLP-1 Market Industry Trends and Opportunities - Precedence Research

GLP-1 Market Industry Trends and Opportunities  Precedence Research

South Africa escalates Ozempic crackdown as doctors risk losing licences over copycat weight-loss drugs - Business Insider Africa

South Africa escalates Ozempic crackdown as doctors risk losing licences over copycat weight-loss drugs  Business Insider Africa

GLP-1 drugs – Ozempic and Wegovy – linked to lower use of risky substances - Labmate Online

GLP-1 drugs – Ozempic and Wegovy – linked to lower use of risky substances  Labmate Online

Study Compares GLP-1 Drugs on Their Benefits, Harms - MedPage Today

Study Compares GLP-1 Drugs on Their Benefits, Harms  MedPage Today

South African regulators issue recall of Ozempic copies - Reuters

South African regulators issue recall of Ozempic copies  Reuters

Peptron says Lilly research remains on track as Mounjaro remarks send shares to lower limit - koreabiomed.com

Peptron says Lilly research remains on track as Mounjaro remarks send shares to lower limit  koreabiomed.com

Regulators tighten noose on recalled GLP-1 medicines - Mail & Guardian

Regulators tighten noose on recalled GLP-1 medicines  Mail & Guardian

Nasty side effects of weight loss drugs no one talks about - The Nightly

Nasty side effects of weight loss drugs no one talks about  The Nightly

Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk

(MedPage Today) -- Analysis of hundreds of thousands of patient records showed differing risks for autoimmune disorders for new users of the more recent types of antidiabetic…

Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock. - The Globe and Mail

Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.  The Globe and Mail

South African regulators issue recall of Ozempic copies - WTVB

South African regulators issue recall of Ozempic copies  WTVB

GLP-1s and Liver Cancer Recurrence; IBS Acupuncture; Transmural Healing in Crohn's

(MedPage Today) -- Diabetes patients with hepatocellular carcinoma (HCC) experienced longer time to HCC recurrence and longer survival when they initiated a GLP-1 agonist rather…

Big weight loss, low quality of life: The obesity drug that is changing everything - The Times of India

Big weight loss, low quality of life: The obesity drug that is changing everything  The Times of India

Ozempic and Wegovy Dosing Errors Drove Poison Control Calls from 1,500 to 8,000 a Year - Medical Daily

Ozempic and Wegovy Dosing Errors Drove Poison Control Calls from 1,500 to 8,000 a Year  Medical Daily

GLP-1 weight-loss drug market plateaus as semaglutide, tirzepatide sales flatten in June - Moneycontrol.com

GLP-1 weight-loss drug market plateaus as semaglutide, tirzepatide sales flatten in June  Moneycontrol.com

GLP-1 weight-loss drug market plateaus as semaglutide, tirzepatide sales flatten in June - Moneycontrol.com

GLP-1 weight-loss drug market plateaus as semaglutide, tirzepatide sales flatten in June  Moneycontrol.com

GLP-1 fight: Doctors warned amid urgent recall of all iDexis compound products - News24

GLP-1 fight: Doctors warned amid urgent recall of all iDexis compound products  News24

The Ozempic and Wegovy mistake sending thousands to poison control - ScienceDaily

The Ozempic and Wegovy mistake sending thousands to poison control  ScienceDaily

Obesity drugs bring weight loss but not better quality of life, study finds - Yahoo News Singapore

Obesity drugs bring weight loss but not better quality of life, study finds  Yahoo News Singapore

Obesity drugs bring weight loss but not better quality of life, study finds - Yahoo News Australia

Obesity drugs bring weight loss but not better quality of life, study finds  Yahoo News Australia

Ozempic & Wegovy Maker To Evaluate Long-Acting GLP-1 Implant That Could Last Up To A Year - Health and Me

Ozempic & Wegovy Maker To Evaluate Long-Acting GLP-1 Implant That Could Last Up To A Year  Health and Me

Wegovy, Ozempic regain weight as Indian generics fall behind - The Economic Times

Wegovy, Ozempic regain weight as Indian generics fall behind  The Economic Times

GLP-1 Users Say Ozempic Feet Side Effect Is Hard to Ignore - The Daily Beast

GLP-1 Users Say Ozempic Feet Side Effect Is Hard to Ignore  The Daily Beast

FDA receives applications for generic Mounjaro, Zepbound - AOL.com

FDA receives applications for generic Mounjaro, Zepbound  AOL.com

STAT+: Europe will accelerate its review of RevMed’s drug

Kailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech news from The Readout

GLP-1 Users Say 'Ozempic Feet' Side Effect Is Harder to Ignore Than ‘Ozempic Face’ - Yahoo Health

GLP-1 Users Say 'Ozempic Feet' Side Effect Is Harder to Ignore Than ‘Ozempic Face’  Yahoo Health

The Future of Obesity Care Goes Far Beyond Ozempic, Wegovy, and Zepbound - SciTechDaily

The Future of Obesity Care Goes Far Beyond Ozempic, Wegovy, and Zepbound  SciTechDaily

New weight loss pill beats oral Ozempic in major trial - ScienceDaily

New weight loss pill beats oral Ozempic in major trial  ScienceDaily

New weight loss pill beats oral Ozempic in major trial - ScienceDaily

New weight loss pill beats oral Ozempic in major trial  ScienceDaily

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy - Gizmodo

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy  Gizmodo

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

(MedPage Today) -- Americans' use of GLP-1 injectables for weight loss reached a record high, nearly quadrupling since 2024, according to a national Gallup poll. For patients with…

STAT+: ‘Secret shopper’ study probes GLP-1 telehealth sites

In this edition of STAT Health Tech: A 'secret shopper' study of telehealth sites prescribing GLP-1s, news about Epic, Anthropic, and brain implants.

Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes - Newswire Canada

Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes  Newswire Canada

Semaglutide vs. Tirzepatide vs. Orforglipron for Weight Loss - Health US News

Semaglutide vs. Tirzepatide vs. Orforglipron for Weight Loss  Health US News

FDA receives applications for generic Mounjaro, Zepbound - NewsNation

FDA receives applications for generic Mounjaro, Zepbound  NewsNation

Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes - Yahoo! Finance Canada

Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes  Yahoo! Finance Canada

Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes - Yahoo Finance

Health Canada approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes  Yahoo Finance

FDA receives applications for generic Mounjaro, Zepbound - Yahoo

FDA receives applications for generic Mounjaro, Zepbound  Yahoo

In U.S., GLP-1 Usage Reaches New High - Gallup News

In U.S., GLP-1 Usage Reaches New High  Gallup News

Chart of the Day: Weight loss drugs emerge as a major driver of global pharma market - Moneycontrol.com

Chart of the Day: Weight loss drugs emerge as a major driver of global pharma market  Moneycontrol.com

Secret Shopper Study Warns About Online GLP-1 Sellers

(MedPage Today) -- Two-thirds of online GLP-1 receptor agonist sellers did not require speaking with a clinician ahead of a prescription, a secret shopper study revealed. Out of…

Oral GLP-1 Drug May Simplify Diabetes Treatment

(MedPage Today) -- At the American Diabetes Association annual meeting, results from the ACHIEVE-5 trial showed that adding oral orforglipron (Foundayo) to basal insulin…

How GLP-1 Therapies Could Impact Bone Density, Muscle Loss - Drug Topics

How GLP-1 Therapies Could Impact Bone Density, Muscle Loss  Drug Topics

STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight

A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical care.

I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill - HELLO! Magazine

I've been on GLP-1s for 16 months – here's why I won't be swapping to the new weight loss pill  HELLO! Magazine

Zepbound Side Effects: Risks, Injuries & Lawsuit Updates - Motley Rice

Zepbound Side Effects: Risks, Injuries & Lawsuit Updates  Motley Rice

Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available - Healthline

Mounjaro, Zepbound: Generic GLP-1 Drugs May Soon Be Available  Healthline

A Podiatrist Explains "Ozempic Feet," the GLP 1 Side Effect Nobody Warned You About - Yahoo Creators

A Podiatrist Explains "Ozempic Feet," the GLP 1 Side Effect Nobody Warned You About  Yahoo Creators

People Are Sharing The Things They Think Will Be “Inevitable Outcomes” Of GLP-1s Over The Next 20 Years - BuzzFeed

People Are Sharing The Things They Think Will Be “Inevitable Outcomes” Of GLP-1s Over The Next 20 Years  BuzzFeed

Ozempic Games - The New Indian Express

Ozempic Games  The New Indian Express

Where to buy Ozempic, Wegovy and Mounjaro in the UK – we compare providers and prices - Mamabella

Where to buy Ozempic, Wegovy and Mounjaro in the UK – we compare providers and prices  Mamabella

Ozempic vs Wegovy vs Mounjaro: What South Africans need to know about the weight-loss injections - IOL

Ozempic vs Wegovy vs Mounjaro: What South Africans need to know about the weight-loss injections  IOL

Medicare Is Now Covering Some GLP-1s for Weight-Loss for $50. Here's What to Know

(MedPage Today) -- Popular -- and expensive -- GLP-1 agonists for weight loss just got a lot cheaper for many older Americans. Starting this week, the federal government is…

Twice-Monthly GLP-1 Shot Helps Manage Blood Sugar, Weight Loss in Trial - Healthline

Twice-Monthly GLP-1 Shot Helps Manage Blood Sugar, Weight Loss in Trial  Healthline

FDA Accepts Sandoz Applications for Generic Tirzepatide - Drug Topics

FDA Accepts Sandoz Applications for Generic Tirzepatide  Drug Topics

Roughly one in eight American adults is now on a GLP-1 drug like Ozempic — a class that grew out of a hormone one Bronx doctor found in Gila monster venom, then patented himself after his own employer passed on it - Silicon Canals

Roughly one in eight American adults is now on a GLP-1 drug like Ozempic — a class that grew out of a hormone one Bronx doctor found in Gila monster venom, then patented himself…

Does Medicare Cover Weight-Loss Medications Like Zepbound or Wegovy? - GoodRx

Does Medicare Cover Weight-Loss Medications Like Zepbound or Wegovy?  GoodRx

Former Texas Middle School Principal Arrested for Allegedly Selling Weight Loss Drugs to Teachers - Us Weekly

Former Texas Middle School Principal Arrested for Allegedly Selling Weight Loss Drugs to Teachers  Us Weekly

Doctors explain what really happens when you stop taking Ozempic and other GLP-1 drugs - Yahoo Health

Doctors explain what really happens when you stop taking Ozempic and other GLP-1 drugs  Yahoo Health

Everything you need to know about GLP-1s for weight loss - The Pharmaceutical Journal

Everything you need to know about GLP-1s for weight loss  The Pharmaceutical Journal

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug - Woman's World

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug  Woman's World

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug - AOL.com

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug  AOL.com

GLP-1s Linked to Systemic Clinical Risk Reduction in Hidradenitis Suppurativa

(MedPage Today) -- Patients with hidradenitis suppurative (HS) and a history of GLP-1 receptor agonist use for diabetes or obesity had significantly lower rates of multiple…

STAT+: More signs that GLP-1s may help with peripheral artery disease

Anthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The Readout

Eligible seniors can get GLP-1s for $50 a month for weight loss alone - ABC News - Breaking News, Latest News and Videos

Eligible seniors can get GLP-1s for $50 a month for weight loss alone  ABC News - Breaking News, Latest News and Videos

GLP-1s After Surgery; Retatrutide for Pulmonary Hypertension? Vit D for Prediabetes

(MedPage Today) -- Incretin-based therapies after bariatric surgery were associated with clinically meaningful augmented weight loss in a dose- and timing-dependent manner,…

Will Mounjaro and Zepbound get their first US generic rival? - Life Sciences IP Review

Will Mounjaro and Zepbound get their first US generic rival?  Life Sciences IP Review

Serena Williams Reveals 34-Pound Weight Loss on Zepbound, Not Ozempic - AOL.com

Serena Williams Reveals 34-Pound Weight Loss on Zepbound, Not Ozempic  AOL.com

1st generic semaglutide injection for weight loss approved: Health Canada - CBC

1st generic semaglutide injection for weight loss approved: Health Canada  CBC